NeurologyLive Friday 5 — February 14, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 14, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Podcast: No Relief for Rising MS Drug Prices
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Daniel Hartung, PharmD, MPH.
2: New Guidelines for Addressing Sleep Disturbance in Autism Spectrum Disorder
Following the 2011 guideline development process, this 2020 guideline focused on addressing a number of types of sleep disturbance in children and adolescents with autism spectrum disorder.
3: Can Better Stress Coping Limit Tau Deposition?
Stress coping abilities may have a direct impact on the early accumulation of tau pathology.
4: Advice for Neurologists Treating Patients With Sialorrhea
Expert panelists provide advice to neurologists to incorporate the use of botulinum toxic injections into their practice to treat sialorrhea in Parkinson disease.
5: Smartphones in the Clinic: How Patient Videos Can Change Seizure Diagnosis
William O. Tatum, DO, director, Comprehensive Epilepsy Center, and professor of neurology, Mayo Clinic College of Medicine & Health Sciences, discussed the additive value of smartphone video technology in diagnosing epilepsy.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
